Certified by Founder Lodge
Maze Therapeutics
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $115,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have ena
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 04 ,2024 | Series D | $115,000,000 |
Foresite Capital
Casdin Capital, LLC
Janus Henderson Investors
Third Rock Ventures
Logos Capital
Matrix Capital Management Company, L.P.
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
